Lumateperone 42 mg: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
8
Conditions studied
2
US states with sites
1
Countries
Phase breakdown
Phase 3 1
Phase 4 1
Conditions being studied
| Condition | Trials |
|---|---|
| Apathy | 1 |
| Bipolar Depression Depressed Phase | 1 |
| Bipolar disorder | 1 |
| Depression | 1 |
| Obesity | 1 |
| Obesity & Overweight | 1 |
| Schizophrenia | 1 |
| Schizophrenia; Psychosis | 1 |
Recruiting trials involving Lumateperone 42 mg
- Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
- The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
Common questions
How many recruiting trials involve Lumateperone 42 mg?
2 recruiting trials across 8 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.